Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
Technology Networks
 
Register | Sign in
Home Page
  About Us

Technology Networks

Established since 2000, Technology Networks is a major online publisher focused on delivering relevant information to the life sciences and drug discovery communities.

In addition to this, our main website, we also produce LabTube - the main scientific video site and ePosters, The Online Journal of Scientific Posters.

Our Communities
Agrigenomics Biologics and Bioprocessing
Biomolecular Screening Cell Culture Chemical Process Scale Up
Chromotography Crystallography Environmental Analysis
Food and Beverage Forensic Science & Clinical Toxicology Gene Silencing
Genomics Genotyping and Gene Expression Immunology
Informatics Lab-on-a-Chip
LIMs and ELNs Market Reports Mass Spectrometry
Medicinal Chemistry Metabolomics and Lipidomics Molecular and Clinical Diagnostics
Next Gen Sequencing PharmaOutsourcing Proteomics
qPCR Spectroscopy Stem Cells, Cellular Therapy & Biobanking

Scientific News
Peptide Mimics as a Drug Target for Ebola
University of Utah researchers create a tool to develop treatments for Ebola using Protein Technologies’s peptide synthesizer.
Personalized Ovarian Cancer Vaccines
UConn Researchers have found a new way to identify protein mutations in cancer cells.
Potential Therapy for Myasthenia Gravis
Penn study demonstrates efficacy of potential therapy for autoimmune disorder of muscle weakness.
Candidate H7N9 Avian Flu Vaccine Works Better With Adjuvant
Results of large NIH-sponsored trial demonstrate improved vaccine response when an adjuvant was used.
Monkey Antibodies Help Fight Virus
Details of monkey antibodies against chikungunya virus could help to fight the disease in humans.
Calixar and VirPath Develop an Innovative Manufacturing Process
A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines.
New Approach To Arthritis Treatment
A new approach to arthritis treatment, which avoids unforeseen side-effects by delivering drugs exclusively to affected inflamed joints, has been developed by researchers at Queen Mary University of London.
A New Molecule Allows for an Increase in Stem Cell Transplants
A clinical study using UM171 and a new type of bioreactor developed for stem culture will be initiated in December 2014.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Salmonella - Why Live Vaccines May Be Most Effective
University of Cambridge researchers investigated the effectiveness of vaccines against Salmonella.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv